November 19, 2019
Health Partners to follow Statewide Preferred Drug List effective 1/1/2020
All Pennsylvania Medical Assistance (MA) programs must follow the Pennsylvania Preferred Drug List (PDL) starting on January 1, 2020. That means Health Partners members who are currently taking a non-preferred medication(s) will have to switch to the preferred state alternative or have their doctor fill out a prior authorization request to continue their current medication(s). Impacted members were notified of this change on October 31, 2018.
This table lists the top 10 impacted medications, along with their preferred alternative specific to Health Partners members:
|Non-Preferred Drug||Preferred Alternative|
|FREESTYLE LITE TEST STRIP||CONTOUR NEXT TEST STRIP|
|BASAGLAR 100 UNIT/ML KWIKPEN||LANTUS SOLOSTAR 100 UNIT/ML|
|HUMALOG 100 UNITS/ML KWIKPEN||INSULIN LISPRO 100 UNIT/ML PEN|
|KETOCONAZOLE 2% CREAM||CLOTRIMAZOLE 1% CREAM|
|ADMELOG SOLOSTAR 100 UNIT/ML||NOVOLOG 100 UNIT/ML FLEXPEN|
|BREO ELLIPTA 100-25 MCG INH||FLUTICASONE-SALMETEROL 250-50|
|TOUJEO SOLOSTAR 300 UNIT/ML||LANTUS SOLOSTAR 100 UNIT/ML|
|BREO ELLIPTA 200-25 MCG INH||FLUTICASONE-SALMETEROL 500-50|
|NAPROXEN SODIUM 550 MG||NAPROXEN 500 MG|
|QVAR REDIHALER 80 MCG||FLOVENT 100 MCG DISKUS|
If you have questions or concerns, please contact Health Partners Member Relations at 1-800-553-0784 (TTY 1-877-454-8477).